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HIV disproportionately impacts transgender communities and the majority of new infec-
tions occur in the Southern United States. Yet, limited data exists on contextual realities of
HIV vulnerability and healthcare needs among transgender individuals in the Deep South.
Addressing this gap in the literature, we assess the health needs, including barriers and
facilitators to accessing healthcare, including and beyond HIV, from the perspective of
transgender men and women in Mississippi. Between June-August 2014, in-depth, semi-
structured qualitative interviews (n = 14) were conducted with adult transgender persons
at an LGBT healthcare setting in Jackson, Mississippi. In-depth interviews lasted between
60–90 minutes and followed semi-structured format (themes probed: HIV vulnerability,
healthcare needs, and availability of gender-affirming medical care). Audio files were tran-
scribed verbatim and analyzed using Dedoose (v.6.1.18). Among participants (mean age
= 23.3 years, standard deviation = 4.98), 43% identified as a transgender man or on a
transmasculine spectrum, 43% as Black, and 21% self-reported living with HIV. HIV-
related services were frequently described as the primary gateway to accessing health-
care needs. Nonetheless, participants’ primary health concerns were: gender affirmation
processes (hormones, silicone, binding/packing); mental health; and drug/alcohol use.
Stigma and discrimination were commonly reported in healthcare settings and health-
related information was primarily attained through social networks and online resources.
Results highlight gender identity alongside race and pervasive marginalization as key
social determinants of transgender health in Mississippi. As Mississippi is one of several
states actively debating transgender access to public accommodations, findings
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underscore the need to treat transgender health as a holistic and multidimensional con-
struct, including, but moving beyond, HIV prevention and care.
Introduction
Increasing transgender visibility has drawn attention to the range of health disparities and
unique public health needs faced by transgender individuals across the United States. Available
literature reports that close to 1 million people in the US self-identify as transgender, approxi-
mately 0.3% of adults. [1] Transgender individuals are disproportionately burdened by HIV
and AIDS, alcohol, tobacco, and drug abuse, obesity, cardiovascular disease, and certain can-
cers. [2–6] Additionally, high prevalence of mental health problems, including depression,
anxiety, and suicidal ideation and attempts, have been documented and are associated with
discrimination and victimization. [7–10]
To date the emerging literature on transgender health has been largely focused on HIV due
its heightened impact among transgender women. As evidenced, the prevalence of HIV
among transgender women in the US is 21.7% (95% CI 18.4–25.1%). [11] and has been esti-
mated to be as high as 24.9% among Black transgender women. [10] In addition the epidemic
is disproportionately clustered among key geographic regions. The Southern US accounts for
37.1% of the American population, but 57.6% of all individuals newly diagnosed with HIV and
37.6% of all individuals newly diagnosed with AIDS cases reside in the South. [12] Nonethe-
less, an understanding of the factors driving HIV disparities is limited among transgender
individuals in the South. Public health efforts are lacking, and Mississippi, in particular, is
experiencing an HIV and AIDS crisis as the state with the highest HIV incidence and AIDS
mortality in the nation. [13]
Nonetheless, the focus on HIV has also had the consequence of overshadowing the compre-
hensive health needs of transgender individuals. For example, a range of transgender-specific
barriers, from lack of provider knowledge and competency to provider rejection, violence, and
discrimination, further compounds these health disparities. [14–17] Importantly, one-fifth of
respondents in the National Transgender Discrimination Survey—the only nationally repre-
sentative data on transgender health available–reported denial of care due to their gender iden-
tity, with higher numbers among transgender people of color. [10] These experiences drive
many individuals to seek care outside legal medical professions, [15,16] or to avoid seeking
care altogether. [10] Further understanding the mechanisms through which stigma and dis-
crimination function to limit access to care for transgender individuals is particularly impor-
tant in the context of federal programs such as the Affordable Care Act (ACA). [18,19] Under
Section 1557 of the ACA, federal protections prohibit discrimination on the basis of sex for
any healthcare entity receiving federal funds, and, in 2016, a formal clarification was made to
include anti-transgender discrimination. However, private insurers not receiving federal funds
are not subject to the ruling, and current controversy regarding a possible rollback of Section
1557 makes the coverage of transgender individuals and transition-related care vulnerable to
misinterpretation and discontinuation. [18]
The majority of literature exploring health needs of transgender people has focused on met-
ropolitan settings in states that have historically enforced transgender-protective policies [20]
(i.e., Democratic leaning) and the health needs of transgender people in the Deep South are
relatively unknown. [21,22] As a result, limited scholarship has assessed the relationship
between structural stigma, defined as the societal-level conditions including institutional
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policies and cultural norms that constrain opportunities, resources, and well-being, [9] and
heath outcome for transgender individuals in the Deep South. The structural stigma experi-
enced by transgender individuals in the South remains substantial and exacerbated by legisla-
tion that ignores trans-inclusive Title IX guidelines and limits birth certificate changes. [23]
This is particularly relevant today as evidenced by the most recent wave of “bathroom bills,”
whereby states such as North Carolina, South Carolina, and Oklahoma have passed or intro-
duced laws requiring public bathrooms to be segregated by sex assigned at birth. Especially in
Mississippi, where recent legislation (i.e., House Bill 1523) [24] further restrict access to critical
health services to gender and sexual minority patients, research is urgently needed to assess
transgender health needs.
The awareness of transgender health in public health underscores significant advancements
in understanding the associations between gender identity and health disparities. However,
limited research to-date has taken into account the spectrum of health-related needs, including
and extending beyond HIV. Further attention must be paid to the health and service needs of
transgender individuals residing in the Deep South (referring to a subregion in the Southern
United States including Alabama, Georgia, South Carolina, Mississippi, and Louisiana).
Addressing this gap, this study sought to provide a qualitative portrait of the health needs from
the perspective of transgender men and women in Mississippi by assessing: (1) healthcare
needs and (2) barriers and facilitators to accessing healthcare.
Methods
Between June-August 2014, in-depth qualitative interviews (N = 14) were conducted with
adult transgender persons at an LGBT healthcare setting in Jackson, Mississippi. The Institu-
tional Review Board (IRB) from the Miriam Hospital at Brown University in Providence,
Rhode Island and University of Mississippi Medical Center in Jackson, Mississippi reviewed
and approved all study procedures.
Data collection procedures
In efforts to maximize the variety of perspectives obtained in sampling, a purposive sampling
approach [25] was implemented that actively recruited people from the transgender commu-
nity who identified on a transfemine and transmasculine spectrum, as well as, people who self-
described their race as Black or White. Recruitment was conducted with clinical staff and
potential participants were identified through the course of routine clinical care. Potential par-
ticipants were informed that this study consisted of a one-time anonymous qualitative inter-
view seeking to better understand healthcare needs of the transgender community in
Mississippi and barriers and facilitators to accessing healthcare. Research procedures were
described orally by study staff and written informed consent to participate was obtained at the
beginning of each interview. Participants were compensated $30 for their time.
Interviews lasted 60–90 minutes and were conducted in a private and confidential room at
the LGBT healthcare center which participants were familiar with. All interviews were audio
recorded, and followed a semi-structured interview guide addressing topics related to: gender
identity, access medical services, experiences with providers, health needs, and facilitators to
healthcare. Wording of interview questions were adjusted to accommodate the pronouns of
choice identified by participants, to engage in open-ended discussion, and follow-up probes.
All interviews were conducted by Perez-Brumer, a Latina cisgender female researcher, who
holds an MSc and is currently a PhD candidate. She is trained in qualitative methodology, pub-
lic health, gender and women’s studies, and social epidemiology and has almost ten years of
experience conducting research with transgender communities.
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While the analytic sample size from which these results are derived are from 14 in-depth
qualitative interviews, 6 formative interviews (which were not included in this analysis) where
conducted with community leaders to modify and adapt final semi-structured interview guide
utilized in interviews to this specific context. Given the preliminary nature of the research
questions, which aimed to broadly assess the healthcare needs and barriers and facilitators to
healthcare among transgender people in Mississippi, interviews were conducted until a satura-
tion was achieved. [26,27] Notably, due to the scant available research in this context, these
findings serve as a first step to inform scholars and public health practitioners of the health
needs and more in-depth mixed-methods follow-up assessments are encouraged.
Analytical approach
Interview audio recordings were transcribed verbatim. Transcripts were analyzed using an
immersion crystallization approach to identify themes and relationships between themes. [28]
Initial set of themes was transformed into codes and coding was carried out using Dedoose
v.6.1.18, (2014, Los Angeles, CA: SocioCultural Research Consultants, LLC, www.dedoose.
com). Three members of the study team created a codebook which included codes, brief
descriptions, and illustrative quotations. Prior to coding, coders completed training sessions to
practice applying the final set of codes to a subset of excerpts. To finalize the codebook and
analytic plan, the constant comparison method was used to compare and re-review coded
transcript data to ensure that coded data were as representative as possible.
Results
Among participants (mean age = 23.3 years, standard deviation = 4.98), slightly fewer than
half (43%) identified as a transgender man or on a transmasculine spectrum, and 43% self-
reported their race as Black. While HIV serostatus was not explicitly asked of participants, 21%
discussed living with HIV. See Table 1 for demographic characteristics. Results from thematic
analysis of qualitative interviews are grouped into three major emergent themes: (1) Health
needs beyond HIV; (2) Barriers to engagement in routine medical care; and (3) Economic,
social marginalization, and health vulnerabilities: (1) Health needs beyond HIV; (2) Barriers to
engagement in routine medical care; and (3) Economic, social marginalization, and health
vulnerabilities.
Health needs beyond HIV
Across interviews the theme that HIV services were perceived to dominate and minimize
other healthcare needs among the transgender community emerged. For example, one partici-
pate stated: “I guess you could call it LGBT health, you know, [but] it’s all kind of associated with
HIV, which is kind of crazy” [Transmasculine, White, 25 years old].
While services specifically for those with HIV were voiced as an important and needed
resource, there were also tensions associated with restricting the eligibility of services based on
HIV status. One participant described: “[A certain clinic is] for patients only who have HIV
so. . . I couldn’t go there” [Transmasculine, White, 20 years old]. Across interview narratives,
vulnerability to HIV was perceived as more relevant to transgender women compared to trans-
gender men: “I think HIV plays a big part in the trans community when it comes to trans
women” [Transmasculine, Black, 25 years old].
The association between HIV and being transgender was commonly underscored as a
recurrent source of stigma encountered in healthcare settings and often resulted in medical
mistrust. When discussing a recent hospitalization due to pneumonia, one participant
expressed discomfort and anger over the assumption that they were living with HIV: “after
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they found out I was trans, they treated me like. . . an HIV-ridden gay male and told me that my
pneumonia was not pneumonia, it was that I had HIV, which I don’t have. That was very, very
upsetting. . . [they] find out that I’m trans and then instead of just focusing on the actual issue. . .
it’s suddenly all different because you’re a deviant” [Transfeminine, White, 24 years old].
When explicitly asked about the top three healthcare needs for the transgender community
in Mississippi, participants most commonly identified access to safe and legal cross-sex hor-
mones (27.0%), transgender health trained providers (18.9%), and mental health services
(16.2%).
Barriers to engagement in routine medical care
A second emergent theme were that barriers to engagement in routine medical routine were
deeply intertwined with pervasive stigma and discrimination within clinical settings. As illus-
trated: “I feel like transgender people in the medical community are almost looked at as an “it”,
instead of a normal patient” [Transmasculine, White, 20 years old].
Narratives highlighted negative interactions with receptionists, judgmental stares in the
waiting rooms, and rejection and disgust from providers during scheduled visits. When calling
to inquire about endocrinology services, one participant recounted:
“I called around. . . and I said do any of your doctors do HRT [hormone replacement ther-
apy]? And they’re like, yeah, do you need estrogen? Do you have problems with that? And I
was like, no ma’am, I don’t. I was like, I need testosterone. And she was like, what? I said I am
a transgender patient and she said, oh, we just don’t do that, click and hung up”
[Transmasculine, White, 19 years old].
Transphobia expressed by providers and clinic staff was highlighted as a barrier to finding
medical services willing to treat transgender patients. For example: “I’ve been turned down by
five different doctors before I came here. . . because I wanted to start my transition”
Table 1. Demographic characteristics of transgender study participants in Jackson, MS.
Characteristic Gender identitya
n (percentb)
All (n = 14) Transfeminine spectrum (n = 8) Transmasculine spectrum (n = 6)
Age, yearsc
18–24 9 (64) 5 (63) 4 (67)
25–30 4 (29) 2 (25) 2 (33)
31–37 1 (7) 1 (13) 0 (0)
Race/ethnicity
Black 6 (43) 4 (50) 2 (33)
White 7 (50) 3 (38) 4 (67)
Multiracial 1 (7) 1 (13) 0 (0)
Employed 9 (64) 4 (50) 5 (83)
Health insuranced 5 (36) 1 (13) 4 (67)
Living with HIV 3 (21) 3 (38) 0 (0)
a Self-reported gender identity as on the transfeminine spectrum (MTF, male-to-female) or transmasculine spectrum (FTM, female-to-male).
b Percent of sample or subsample. Total percentages may exceed 100 due to rounding error.
c The mean age was 23.3 years, with a standard deviation of 4.98.
d Insured status includes coverage via Medicaid.
https://doi.org/10.1371/journal.pone.0202389.t001
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[Transfeminine, White, 37 years old]. Another participant explained that after years of care
from their family physician, the rejection of a trusted medical provider was deeply felt: “That
hurt. I cried for days over that [rejection] because he was the one I really wanted to take care of
me because I really trusted him. . . but he said he didn’t believe in it [being transgender], that he
would not do it” [Transfeminine, Black, 27 years old]. Furthermore, in seeking top surgery, one
individual emphasized the consistent presence of discrimination based on gender identity and
outrage due to transphobic experiences with medical providers:
“. . .surgeons out here are cruel, when it comes to trans. [They say] we don’t do implants on
men. I’m saying to myself like that’s so rude. Like I’m clearly a transgender person. I live my
life as a woman. How dare you?”
[Transfeminine, Black, 25 years old].
Lack of provider knowledge related to transgender-specific health needs often drove pro-
vider stigma and discrimination. For example:
“I go in and say hey, I need a Pap, and I look like this [masculine physical presentation],
they’re gonna say. . . what? You need to get your prostate checked? No, I need a Pap. Prostate?
Pap. Then they’re gonna be asking questions, well why do you need that? And. . . so when you
have somewhere you don’t have to go through all the questions and interrogations and feeling
uncomfortable. . . ‘cause after awhile you’re gonna be like, okay, you know what? Just forget it.
I’ll just deal with it on my own”
[Transmasculine, Black, 27 years old].
Participants reported a sense of demoralization accompanying their experiences: “discrimi-
nation and stigma. . . [is] like getting punched in the gut by a really, really strong, like, body-
builder or something, like it knocks the wind out of you and like you have to sit there and think
about that all day” [Transmasculine, White, 19 years old]. This led many to use informal ave-
nues of care, such as black markets, for hormones or injectable silicone. One participant sum-
marized these sentiments of exasperation with formal medical care:
“. . .when you have gender dysphoria, like when you just really cannot stand yourself, you’re
desperate, because you know you don’t have them in your resources, then you’ll take whatever
you can whether it’s life-threatening or not. . . I’ll just go ahead and do it and I’m sure that’s
how other trans-people think”
[Transfeminine, Black, 27 years old].
Economic, social marginalization, and health vulnerabilities
Narratives also highlighted the critical intersection between economic and social marginaliza-
tion, health vulnerabilities, and limited access to health care. Economic marginalization was
primarily referenced when discussing lack of employment opportunities, especially when tran-
sitioning, contributing to the high prevalence of drug use and engagement in survival sex
work: “A lot of us become homeless, don’t have anywhere to go so we turn to drugs. We turn to
sex. We start being careless, start slipping up” [Transfeminine, Black, 25 years old]. Given the
dearth of economic opportunities several participants described the frequency of sex work. For
example, “Let me tell you something, it’s not even about being transgender, a lot of people prosti-
tute because they don’t got money” [Transmasculine, White 19 years old]. Yet, despite the reality
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of limited employment opportunities, both poverty and sex work were stigmatized within the
community:
“You’re going to find a lot of people that say, oh, she’s a coin girl. . . [and] at the same time
those are the same people saying, she’s nasty, she’s an escort, she sells to everybody, she’s a
prostitute. People, they don’t want to see you just sleeping on people’s floors, not just being
broke, but at the same time they don’t want to see you prostitute”
[Transfeminine, Black, 22 years old].
Dimensions of social marginalization were also described as interwoven with sexual risk
behavior. For some participants, sexual risk taking, such as, engaging in sex with multiple part-
ners was described in part as an external form of seeking affirmation of their sexuality and
attractiveness. For example:
“I’ve learned now that I was just trying to feel feminine, I guess. I thought that if tons of men
wanted to be with me that meant that I was succeeding in what I wanted. I was feminine, and
pretty, and wanted, you know, by somebody. . . so that’s why I did it at first and I was sleeping
with multiple people. . . I think. . . well, I slept with a few people and thank God I didn’t catch
anything”
[Transfeminine, White, 24 years old].
For other interviewees, while sexual attraction was a component, additional factors, such as,
employment needs and economic motivations further influenced sexual risk including limited
condom use.
“Okay, the three guys I had been with before him [boyfriend] didn’t wanna use a condom, so,
um, which may be dumb but I was okay with them not using a condom. They were hot and
they said they were clean. I trusted that. I’m clean. Um, so I trust them. I mean I would want
guys to use a condom but it’s like I’m not gonna fight about it especially if they are paying”
[Transfeminine, Black, 18 years old].
Importantly, these experiences with economic and social marginalization were described in
relation to race. Racism, described by both White and Black participants, emerged as a crucial
modifier to existing health disparities. As described, “Yeah it’s hard for Blacks in Mississippi,
it’s even harder when you are trans” [Transmasculine, White, 20 years old]. Another participant
noted:
“It’s always been harder on Blacks in general ‘cause we’re minority and it’s always been a
struggle, but then the fact that you’re Black and you’re trans is a double standard. . . because
people don’t just want us to succeed and then, you know, I think this is why. . . pardon me, I’m
having so much of a problem in the education part of it or whatever, because there are not
that many trans-women doing what I’m doing, going. . . down here in the south that is, going
through school, trying to get my education as anyone else would”
[Transfeminine, Black, 27 years old].
Additionally, race was discussed as a factor that divided resources and community open-
ness from within the LGBT community in Jackson. As described:
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“We have some straight/gay alliances and stuff for the LGBT community here in Jackson. . .we
have a parade, but even that is segregated because it’s more for the Caucasian people that
have the parade and it’s right over there in that area. And that bothers me because you go to
other places and they have whole gay districts, they have huge, national parades. I know so
many people in the LGBT community here that goes to Memphis Pride and Atlanta Pride,
and here when we have Pride it’s not for the whole community”
[Transfeminine, Black, 22 years old].
Discussion
Our study furthers the existing literature on health needs of the transgender community by
including diverse perspectives from transgender Mississippians, a population which to date
has not been scantly represented in public health scholarship. While epidemiological trends
underscoring the disproportionate burden of HIV on transgender women and other health
disparities in the Deep South cannot be ignored, [29,30] it is important to conceptualize trans-
gender health (across both transmasculine and transfeminine needs) as a multidimensional
construct within which HIV is one aspect. While the most pressing healthcare needs described
by the transgender community in Mississippi were access to safe and legal cross-sex hormones,
transgender health trained providers, and mental health services, HIV was described by many
as the only entry point into care. Guided by these findings, we suggest a modified social deter-
minants of health framework that explicitly highlights gender identity as critical to under-
standing transgender health needs in Jackson, Mississippi.
This work presents a first step in showing how social marginalization and manifestations of
transphobia limit willingness to access healthcare, quality of gender-affirming healthcare pro-
vided, and increased health vulnerabilities for transgender individuals in Jackson, Mississippi.
Participant narratives link to a growing body of literature underscoring the critical role of
social determinants of health (SDHs), meaning the structural and social factors that pattern
the distribution of conditions and foster health and access to health services. [31] Yet, there is
only limited attention to gender identity as a SDH, [32] and these results suggest that gender
nonconformity functions as an additional social factor compounding inequalities in health
outcomes and access to health resources. Examples of social determinants of health include
occupation, education, income, gender, and race/ethnicity, [31] and for transgender and gen-
der nonconforming individuals, discrimination due to their gender identity may further mag-
nifies barriers to care and existing health disparities. [14,16,33] Building on these findings,
public health strategies seeking to ameliorate transgender health inequities should understand
gender identity as a factor alongside other sociopolitical factors jointly driving adverse health
outcomes, such as, housing and economic instability and pervasive experiences with
discrimination.
The importance of gender-affirming care, [15,34,35] meaning the interpersonal process by
which an individual’s gender identity and expression are socially recognized, was an emergent
theme across our data. Participants noted the importance of social recognition (e.g. pronoun
usage), and need for medical care awareness and willingness to serve the needs of the transgen-
der community in Mississippi. Furthermore, these results suggest that public health practition-
ers should look beyond HIV when conceptualizing notions of transgender health to
understand SDHs as interactive and cumulative factors. For example, race is a critical factor
that cannot be overlooked, both across the US and specifically in the context of the Deep
South. Previous studies have demonstrated worse health outcomes for transgender people of
color, especially Black transgender women. [22,36,37] Particularly relevant in the context of
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Mississippi where close to 40% of residents are Black, [38] race and gender identity must be
considered as key social factors individually and jointly to assess how multiple cumulative
minority statuses impact health. Frameworks such as the theory of intersectionality [39] and
its applications to understandings of sexual and gender diversity in the Deep South [40] are
may provide utility for work furthering how various social factors intersect to constitute
inequality and vulnerability.
The results presented here have several limitations. These data are from a small qualitative
study from a transgender sample recruited from an LGBT healthcare clinic in Mississippi,
therefore, findings may not be generalizable to all transgender and gender nonconforming
people in Mississippi or the Deep South. Scholars seeking to build on this work should assess
the health needs of transgender individuals not currently engaged in routine care. Semi-
structured interview guides were created with the aim of giving a voice to transgender Mis-
sissippians engaged in care, not to assess healthcare advice attained through informal sources
(i.e., social networks). As such, given the importance of cross-sex hormones, future studies
may want to further investigate pathways of hormone attainment and administration (via
physician and non-physician means). Additional scholarship is also needed on positive inter-
actions and experiences with healthcare providers to provide insight as to how to combat
transphobia and promote transgender cultural competence within healthcare facilities in the
Deep South.
Our study underscores the relevance of gender identity alongside race and pervasive mar-
ginalization as key social determinants of transgender health. These findings suggest that med-
ical provider trainings and access to mental health and cross-sex hormones are vital next steps
in addressing the health needs of transgender individuals in Mississippi. As Mississippi is one
of several states actively debating transgender access to public accommodations, public health
approaches must treat transgender health as a holistic and multidimensional construct, includ-
ing, but moving beyond, HIV prevention and care.
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